Alkali hydrolysis of recombinant proteins allows for the rapid identification of class I MHC-restricted CTL epitopes.
about
Induction of pluripotent protective immunity following immunisation with a chimeric vaccine against human cytomegalovirusRecombinant Newcastle disease virus as a vaccine vector for cancer therapySimultaneous assessment of cytotoxic T lymphocyte responses against multiple viral infections by combined usage of optimal epitope matrices, anti- CD3 mAb T-cell expansion and "RecycleSpot"Critical role of perforin-dependent CD8+ T cell immunity for rapid protective vaccination in a murine model for human smallpoxUse of recombinant protein to identify a motif-negative human cytotoxic T-cell epitope presented by HLA-A2 in the hepatitis C virus NS3 regionComparisons of CD8+ T Cells Specific for Human Immunodeficiency Virus, Hepatitis C Virus, and Cytomegalovirus Reveal Differences in Frequency, Immunodominance, Phenotype, and Interleukin-2 ResponsivenessBrain-infiltrating cytolytic T lymphocytes specific for Theiler's virus recognize H2Db molecules complexed with a viral VP2 peptide lacking a consensus anchor residueCMV pp65 and IE-1 T cell epitopes recognized by healthy subjects.Maintenance of large subpopulations of differentiated CD8 T-cells two years after cytomegalovirus infection in Gambian infants.Peptide vaccines prevent tumor growth by activating T cells that respond to native tumor antigens.Generation of cytomegalovirus-specific human T-lymphocyte clones by using autologous B-lymphoblastoid cells with stable expression of pp65 or IE1 proteins: a tool to study the fine specificity of the antiviral response.CD8(+) T-cell gamma interferon production specific for human immunodeficiency virus type 1 (HIV-1) in HIV-1-infected subjectsIdentification of Chlamydia pneumoniae-derived mouse CD8 epitopes.Induction of antigen-specific Th1-type immune responses by gamma-irradiated recombinant Brucella abortus RB51Mature CD8(+) T lymphocyte response to viral infection during fetal lifeEnhanced Induction of T Cell Immunity Using Dendritic Cells Pulsed with HIV Tat and HCMV-pp65 Fusion Protein In Vitro.CD4-mediated and CD8-mediated cytotoxic and proliferative immune responses to Toxoplasma gondii in seropositive humansCytomegalovirus infection in Gambian infants leads to profound CD8 T-cell differentiationThe peptide p2Ca is immunodominant in allorecognition of Ld by beta chain variable region V beta 8+ but not V beta 8- strains.Therapeutic antitumor response after immunization with a recombinant adenovirus encoding a model tumor-associated antigenActive immunotherapy of cancer with a nonreplicating recombinant fowlpox virus encoding a model tumor-associated antigen.Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccineTransloading of tumor antigen-derived peptides into antigen-presenting cellsCytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases.IL-2 enhances the function of recombinant poxvirus-based vaccines in the treatment of established pulmonary metastases.TCR hypervariable regions expressed by T cells that respond to effective tumor vaccines.Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivoDendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastasesDendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity.Unopposed production of granulocyte-macrophage colony-stimulating factor by tumors inhibits CD8+ T cell responses by dysregulating antigen-presenting cell maturation.Apoptotic death of CD8+ T lymphocytes after immunization: induction of a suppressive population of Mac-1+/Gr-1+ cellsImmunization against endogenous retroviral tumor-associated antigens.Identification of multirestricted immunodominant regions recognized by cytolytic T lymphocytes in the human immunodeficiency virus type 1 Nef protein.Transfectant influenza A viruses are effective recombinant immunogens in the treatment of experimental cancerAnthrax toxin-mediated delivery of a cytotoxic T-cell epitope in vivo.Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells.Enhancing the recognition of tumour associated antigens.Cells infected with Yersinia present an epitope to class I MHC-restricted CTL.Cytomegalovirus (CMV)-Specific Perforin and Granzyme B ELISPOT Assays Detect Reactivation of CMV Infection in Inflammatory Bowel Disease.Sindbis viral vectors transiently deliver tumor-associated antigens to lymph nodes and elicit diversified antitumor CD8+ T-cell immunity.
P2860
Q21092179-DD76EE43-4B5D-4D1D-949E-DD3967800103Q24602728-EE7DF9BB-CC4E-4483-AC43-1AE780F3FFCBQ24814428-C3BAB2B4-FD72-45D8-AC3E-5A01C131D663Q27346933-C2388797-8C56-4438-A4D3-333EE7791678Q27480326-ADC40887-6139-409D-B3B7-25BA9CE53B54Q27487966-0612787D-9D49-4480-A966-B192AEDFDED3Q30452573-5B60949F-A9DF-4A07-9393-51E1924567D3Q33280303-AB57D9D4-EAC1-4E51-B265-AFEE73BC81AAQ33358114-B0F888F3-B9B7-494A-8F91-BC039EAFA04BQ33529578-FDDA1999-18E7-433C-99BC-DC7E7EFD381EQ33803064-4A117E9D-1EC0-43D3-AA0E-FF6DD7B9A8F7Q33998262-404F3BCC-F257-444C-9AAE-2DCE3C2A079DQ34125106-1975A871-6E85-47A1-AAB1-2872CE6D8655Q34231286-248E18EC-B557-4B87-95F0-90F2C607A3A8Q35019349-52C84115-B3DF-403B-BDDC-3C8C2BF46FB9Q35157039-BBE6F17B-293A-41E4-B215-40043AC5033FQ35526423-C4A8507C-E4AF-41DC-89C7-5E5BE3A444A1Q35857674-686BE37C-C043-4E51-8110-714E99995AD4Q35918041-80F6AE03-900F-460E-BFFD-F6BE25BD8AA4Q35945206-A68122AF-164C-4A66-974D-337C40BBE9A5Q35990356-D2587CE7-5441-482A-B169-400FA4AC398DQ36082419-7B7E6C6F-F518-47C6-8646-6E1BDA1D5704Q36084026-10A8E574-0EA1-4BDA-8345-02B65DD7C997Q36088999-1185A9D6-62F0-4901-84CD-8A14B9888D76Q36091993-5B09AC5B-09A7-446F-BDAA-B0865148F5FCQ36137249-06B3B7C9-5A1F-4BA5-9A90-99D3B360EFB0Q36366124-716F1578-BF83-45E5-BC66-0C114ECAD53BQ36380718-C3A68034-2F67-46A2-AE1C-309FA948BAA0Q36380749-C504FB1C-0991-4769-8A5B-BF06D3B8866DQ36432026-3C30B329-4643-4A05-A782-82B048251D5AQ36454468-B9AA08F2-592E-45A7-82EB-C9FA45803B83Q36468362-7EE013E7-D758-45EA-8CB7-4D1F9AC82825Q36637148-CB5993F5-110F-46B0-90C9-C118B3C0157AQ36916492-9293FA26-5788-4494-B5C8-8E56A6F450CAQ37242580-07290C10-1B71-4104-AF2A-FD4B5E137393Q37325176-10A0EDE0-8348-4379-B952-8A372E0DF94AQ37391100-508872C1-F982-49B6-BA12-5D684F38A263Q37468942-59B0F243-38F9-487A-938F-4143A0D28B0BQ37512187-3F1E3DBF-305B-4DA0-9717-C2DD8EA81BDDQ37690452-BCAC542C-2E4B-4B97-BF4C-4CD7F28E9B81
P2860
Alkali hydrolysis of recombinant proteins allows for the rapid identification of class I MHC-restricted CTL epitopes.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Alkali hydrolysis of recombina ...... I MHC-restricted CTL epitopes.
@en
Alkali hydrolysis of recombina ...... I MHC-restricted CTL epitopes.
@nl
type
label
Alkali hydrolysis of recombina ...... I MHC-restricted CTL epitopes.
@en
Alkali hydrolysis of recombina ...... I MHC-restricted CTL epitopes.
@nl
prefLabel
Alkali hydrolysis of recombina ...... I MHC-restricted CTL epitopes.
@en
Alkali hydrolysis of recombina ...... I MHC-restricted CTL epitopes.
@nl
P2093
P1476
Alkali hydrolysis of recombina ...... I MHC-restricted CTL epitopes.
@en
P2093
M J Gilbert
P D Greenberg
S R Riddell
P304
P407
P577
1993-10-01T00:00:00Z